The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
A holistic, value-based care approach is essential for enhancing quality of life in non-small cell lung cancer patients, focusing on treatment side effects and patient preferences. Treatment history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results